A 10-year-old girl with a 4-month history of abnormal gait and dysarthria was admitted to the hospital with altered mental status that had progressed over the previous 3 days in the context of febrile illness. The patient's family reported that she did not use drugs, and the family history is remarkable only for consanguinity. On physical examination, she was confused, having generalized dystonia and bilateral external ophthalmoplegia, and she was anarthric. The results of toxicologic and autoimmune, cerebrospinal fluid, thyroid, bacterial and viral, and metabolic studies, including tandem mass spectrometry, urine for organic acids, and levels of lactic acid, ammonia, acylcarnitines, copper, ceruloplasmin, biotin, and thiamine, were all negative. An initial magnetic resonance imaging (MRI) of the brain showed abnormal signal intensity alterations bilaterally involving the cerebellum, basal ganglia, medial nucleus of the thalamus with a characteristic “bat-wing” appearance, and cerebral cortex (Figure). The affected areas showed increased signal consistent with vasogenic edema on diffusion-weighted images and apparent diffusion coefficient map (not shown). The MRI findings suggested biotin-responsive basal ganglia disease. Sequencing of the SLC19A3 gene identified a pathogenic homozygous mutation c.1264A>G (p.Thr422Ala). The patient was administered thiamine and biotin, achieving marked improvement in her confusion, extraocular movements, and ambulation during the next 4 days. Three months later, she exhibited only mild dysarthria. Repeated brain MRI showed resolution of the vasogenic edema with residual atrophy and gliosis in the basal ganglia (Figure). The physical exam finding of acute to subacute, bilateral external ophthalmoplegia is telling for an energy breakdown, as occurs with biotin-responsive basal ganglia disease, thiamine deficiency, and mitochondrial defects. That exam finding would lead one to examine the midbrain, thalamus, and basal ganglia on brain MRI. Biotin-responsive basal ganglia disease is an autosomal recessive, underdiagnosed pan-ethnic treatable condition, related to thiamine transporter-2 deficiency. It needs to be included in the differential diagnosis for unexplained acute dystonia, bilateral external ophthalmoplegia and encephalopathy, and neuroimaging showing vasogenic edema in the bilateral putamen and caudate nuclei, infratentorial and supratentorial cortex, and brainstem, because a therapeutic trial with thiamine and biotin can be lifesaving.1Ozand P.T. Gascon G.G. Al Essa M. Joshi S. Al Jishi E. Bakheet S. et al.Biotin-responsive basal ganglia disease: a novel entity.Brain. 1998; 121: 1267-1279Crossref PubMed Scopus (136) Google Scholar, 2Serrano M. Rebollo M. Depienne C. Rastetter A. Fernández-Álvarez E. Muchart J. et al.Reversible generalized dystonia and encephalopathy from thiamine transporter 2 deficiency.Mov Disord. 2012; 27: 1295-1298Crossref PubMed Scopus (35) Google Scholar
Read full abstract